CCM
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Valuation metrics are largely irrelevant as the company is operating with negative equity.
- Low P/S ratio
- Negative P/B ratio
- Negative Forward P/E
- No Graham Number possible due to negative earnings/book value
Growth metrics are negative or insufficient to offset operational losses.
- Recent Q/Q EPS improvement
- Negative YoY Revenue growth
- Negative operating margins (-72.10%)
Long-term trend is a steady decline from a previously profitable state.
- Historical periods of profitability (2011-2015)
- 5-year price decline of 89%
- Consistent earnings misses over the last 4 quarters
Critical failure in liquidity and solvency metrics.
- Piotroski F-Score 3/9 (Weak)
- Current Ratio 0.42
- Quick Ratio 0.10
- Debt/Equity 2.22
Dividend strength is 0/100.
- No dividend paid
- No capacity for dividends given negative margins
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for CCM and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
CCM
Concord Medical Services Holdings Limited
Primary
|
-89.0% | -71.8% | -12.3% | -21.4% | +9.6% | +1.8% |
|
LPCN
Lipocine Inc.
Peer
|
-90.5% | -50.9% | -23.7% | -23.5% | -67.6% | +22.7% |
|
ZJYL
Jin Medical International Ltd.
Peer
|
-72.9% | -71.2% | -87.7% | -68.8% | +11.1% | +7.2% |
|
OSRH
OSR Holdings, Inc.
Peer
|
-94.6% | -94.6% | -62.3% | -8.9% | +21.5% | +11.1% |
|
CUE
Cue Biopharma, Inc.
Peer
|
-98.5% | -94.2% | -69.9% | -75.0% | -37.5% | -18.2% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q2 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
CCM
Concord Medical Services...
|
BEARISH | $17.37M | - | -29.0% | -44.6% | $4.0 | |
|
LPCN
Lipocine Inc.
|
BEARISH | $17.37M | - | -54.3% | -% | $2.38 | Compare |
|
ZJYL
Jin Medical International Ltd.
|
BEARISH | $16.87M | 10.78 | 4.8% | 5.8% | $2.15 | Compare |
|
OSRH
OSR Holdings, Inc.
|
BEARISH | $18.11M | - | -20.0% | -% | $0.55 | Compare |
|
CUE
Cue Biopharma, Inc.
|
NEUTRAL | $18.38M | - | -121.1% | -96.9% | $0.19 | Compare |
SEC Filings
Recent regulatory filings from the SEC EDGAR database
Past News Coverage
Recent headlines mentioning CCM from our newsroom.